Perspective Therapeutics, Inc. (CATX)
2.88
+0.07
(+2.49%)
USD |
NYAM |
Dec 26, 16:00
2.82
-0.06
(-2.08%)
After-Hours: 06:46
Perspective Therapeutics EPS Diluted (Quarterly): -0.3495 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Outset Medical, Inc. | -1.003 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
| Picard Medical, Inc. | -0.1915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.97M |
| Revenue (Quarterly) | 0.209M |
| Total Expenses (Quarterly) | 26.18M |
| Enterprise Value | 43.27M |
| Gross Profit Margin (Quarterly) | -270.8% |
| Profit Margin (Quarterly) | -12.43K% |
| Earnings Yield | -50.64% |
| Normalized Earnings Yield | -42.37 |